jwh amb fubinaca synthetic cannabinoids problem decade sensational news reports typically occur result aggressive disorganized behavior users acutely intoxicated compounds initially started appear scene regulators far behind curve first forms sold head shops wrapped paper labelled human consumption went names like k spice plant food typically applied shredded plant material smoked chemical structures compounds resemble typical cannabinoids synthesis relatively straightforward facilitated black market production apart easy availability draw users could take compounds worry standard drug testing protocols work place word street synthetics undetectable typical urine toxicology accurate apart isolated aggressive incidents also deaths associated use epidemics clustered communities eventually like drug epidemics sale compounds prohibited head shop operators prosecuted standpoint addiction practice many compounds create dangerous situation patient dilemma treatment facilities highly addictive people unless familiarity concept delirium producing drugs causing addiction may clear anyone would continue use many people amnestic occurred influence cases develop life threatening conditions result use crave drug acutely treated medical complications another abused drug kind dissociative profile dextromethorphan used high doses leads delirium hallucinations highly addictive jwh designation represents organic chemist john huffman synthesized series compounds cannabinoid receptor agonists goal research produce pharmacological probes study cannabinoid receptors coauthor papers medline several articles popular press including several include opinion original research used produce compounds sale street intoxicants jwh compounds medical literature since pubchem contains structural information jwh compounds protein targets bioassays pubchem also allows user generate structural similarity comparisons bioactivity analyses example activity cb cb receptor jwh compounds synthetics evolved follow familiar pattern development classes addictive compounds subsequent syntheses increasing activity target receptor classes synthetic cannabinoids addition jwh compounds including ur akb ab chminaca ab fubinac others also number psychedelic phenethylamines i i p often sold equivalent drugs obviously guarantees purchases non medical sources results desired chemical effect also class synthetic cathinines referred bath salts structurally similar amphetamines often sold mephedrone mdpv methylone total number synthetics requirement relatively sophisticated analysis detection gas liquid chromatography mass spectrometry frequently leaves acute care addiction physician depending history alone ingested new england journal medicine general review issue january edition full text article available online article details current number new psychoactive compounds identified synthetic cannabinoids illustrated timeline evolution compounds interesting aspect timeline evolution fold increase drug potency jwh amb fubinaca also provide analysis mini epidemic amb fubinaca use brooklyn occurred people exposed required transport medical facilities index case described features blank stare unresponsiveness glasgow coma scale episodic groaning slowed movement extremities term zombielike used descriptor psychiatry term used frequently patients untrained observers lacks meaning patient sweating normal vital signs exception tachypnea respiratory rate screening labs toxicology ecg normal recovered hours discharged authors recovered original herbal product labelled ak karat gold sent well biological samples blood urine users analysis samples analyzed liquid chromatography quadrupole time flight mass spectrometry lc qtof ms amb fubinaca confirmed compound original packet material de esterified product rather parent compound confirmed blood urine patients serum concentrations ng ml discussion authors point potency increase synthetic compounds illustrate attractiveness drug dealers users amb fubinaca produce half million dollars worth product containing mg original compound sprayed shredded plant material strong incentive getting drug street also discuss role inter agency collaboration identifying novel intoxicants similar mini epidemics case entire timeline case molecular identification days many toxicology cases i involved often takes long learn lab using able necessary analysis treating patients addicted compounds challenge foreseeable future people changed synthetics escape drug testing workplace ended addicted compounds psychoactive side effects compounds frequently results downward spiral job loss loss relationships social isolation goes along preoccupation using drug explaining patient family potentially life threatening addiction necessarily deterrent use fatal outcomes possible understanding motivation using drug never tested humans result loss days entire weekend result toxidromes directly indirectly lead fatal outcome may another sign neurobiologically mediated process bypasses rational thought prevention would seem like best approach american society remains fascinated intoxicants americans plenty money spend drugs like political arguments common sense approach better plan living lost poles liberalized drug use prohibition i hope people highest risk using drugs learn avoid without exposure george dawson md dfapa references adams aj banister sd irizarry l trecki schwartz gerona r zombie outbreak caused synthetic cannabinoid amb fubinaca new york engl med jan doi nejmoa pubmed pmid free full text online attribution molecular structures top post generated nlm pubchem interface public domain additional analyses available pubchem i ran two analyses jwh compounds additional information available run analysis supplementary i encountered stories internet chemists originally synthesized compounds course professional careers felt badly morbidity mortality associated use street drugs others pointed intended human use tested humans therefore nobody using keeping mind profit motive suggested nejm article incentives gaming system finding compounds schedule controlled substances i think question sellers buyers drugs responsible outcomes